Pre-clinical evaluation of mRNA-lipid nanoparticles' potency and toxicity: current practices and future directions
{{output}}
Over the last few years, the success of COVID-19 mRNA vaccines has resulted in the emergence of RNA lipid nanoparticles (LNPs) with promising prospects for the prevention and treatment of various diseases. The context of the SARS-CoV-2 pandemic has led to the ... ...
